DLRC Celebrate 20 Years of Regulatory Excellence and Innovation

DLRC, an award-winning global regulatory affairs consultancy supporting the development and licensing of pharmaceutical, biotech, advanced therapy and medtech products worldwide, proudly announces its 20th anniversary. This significant milestone marks two decades of growth, innovation, and commitment to advancing healthcare through regulatory excellence.

Since its founding in 2005, DLRC has grown from a small UK-based consultancy into an internationally recognised organisation. Over the past two decades, DLRC has expanded its footprint across the UK, EU, and US, forming the DLRC Group and building a multidisciplinary team of over 80 regulatory experts. With expertise in more than 50 therapeutic areas, DLRC has become a trusted partner to over 250 clients, navigating the increasingly complex global healthcare landscape.

DLRC’s 20-year journey has been marked by a series of awards and recognitions that reflect its commitment to regulatory excellence, innovation, and people development. These awards showcase DLRC’s global leadership in regulatory consulting and also its dedication to advancing healthcare innovation through world-class regulatory guidance and collaboration.

DLRC 20th Anniversary Press Release Awards Timeline

DLRC’s commitment to sustainability is deeply embedded in its values and operations. In 2024, DLRC published its first annual Sustainable Impact Report, marking a significant milestone in its journey toward responsible growth. The report outlines achievements such as benchmarking carbon emissions, reducing paper usage, and installing energy-efficient LED lighting. DLRC has also launched a volunteering policy and donated over £7,600 to charity in 2023. They support apprenticeships and deliver over 500+ hours of staff training, helping them to maintain high client satisfaction.

DLRC also prioritises employee wellbeing, offering monthly health talks and a network of Wellbeing Champions and Mental Health First Aiders, alongside healthy living initiatives and flexible working policies. By embedding sustainability into every aspect of its business, DLRC is reducing its environmental footprint and also fostering a culture of wellbeing, inclusivity, and community impact.

Hear from DLRC’s CEO, Dianne Lee

“Who would have guessed 20 years ago that DLRC would grow into the organisation we have today! I am absolutely thrilled to have been part of the team that has created this globally operating company, which is responsible for helping so many clients successfully navigate the regulatory path. I’m particularly happy with how we have trained so many people, not just in the consulting team, but across the business. I’m also very excited for the future as we expand our offering in line with European changes for market access and looking at AI tools to increase the efficiency and value of our offering.

Whilst I doubt I will still be an active part of the company after another 20 years, I am confident that the succession plans we have will maintain our forward momentum. A huge thank you to everyone who has been part of the success story of DLRC!”

About DLRC

Advancing Global Patient Healthcare Through Regulatory Excellence

DLRC provides global life science companies with a wide range of regulatory affairs consulting services. DLRC is an award-winning consultancy of more than 80 highly qualified, experienced regulatory professionals and support functions operating from offices in the UK, Germany, and the US. Demonstrating a deep commitment to excellence, the team helps clients navigate the complex regulatory landscape of the life science industry by developing and executing innovative regulatory strategies, and by providing comprehensive support from early development to post-licensing activities for medicinal products and medical devices. DLRC’s regulatory team includes consultant experts in nonclinical, CMC, clinical and MedTech from pharmaceutical, medical device and regulatory agency backgrounds. DLRC has proudly served companies of all sizes and backgrounds in various regulatory jurisdictions.